- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 , CD3 |
Bispecific Antibody |
Columvi® |
1 mg/mL |
– |
0,1 mg |
tba |
tba |
390,00 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
06/2018 |
537,30 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
03/2019 |
537,30 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
04/2023 |
537,30 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
06/2023 |
537,30 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
08/2024 |
597,00 € |
||
TNF alpha |
Monoclonal Antibody |
Simponi® |
100 mg/mL |
– |
4 mg |
-80°C |
03/2025 |
597,00 € |
||
IL-23 |
Monoclonal Antibody |
Tremfya® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2023 |
615,60 € |
||
CD19 |
Monoclonal Antibody |
Uplizna® |
10 mg/mL |
– |
3 mg |
tba |
tba |
3.135,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Remsima® |
10 mg/mL |
– |
3 mg |
tba |
tba |
233,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2020 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2021 |
178,20 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2020 |
178,20 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
01/2025 |
232,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
03/2027 |
233,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Zessly® |
10 mg/mL |
– |
2 mg |
-80°C |
10/2022 |
210,60 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
yes |
2 mg |
-80°C |
11/2024 |
208,00 € |
||
CD22 |
Antibody-drug conjugate (ADC) |
Besponsa® |
0,25 mg/mL |
– |
0,02 mg |
tba |
tba |
1.502,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
09/2024 |
848,00 € |
||
CTLA-4 |
Monoclonal Antibody |
Yervoy® |
5 mg/mL |
yes |
2 mg |
-80°C |
08/2021 |
763,20 € |
||
IL-17A , IL-17A/F |
Monoclonal Antibody |
Taltz® |
80 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
480,60 € |
||
IL13 |
Monoclonal Antibody |
Ebglyss® |
125 mg/mL |
– |
20 mg |
-80°C |
05/2026 |
589,00 € |
||
CD19 |
Antibody-drug conjugate (ADC) |
Zynlonta® |
5 mg/mL |
– |
0,5 mg |
- 80°C |
04/2025 |
2.474,00 € |
||
TGF-beta |
Fusion protein |
Reblozyl® |
50 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
496,80 € |
||
IL-5 |
Monoclonal Antibody |
Nucala® |
100 mg/mL |
– |
4 mg |
-80 °C |
08/2025 |
434,00 € |
||
IL-23 |
Monoclonal Antibody |
Omvoh® |
100 mg/mL |
– |
5 mg |
tba |
tba |
387,00 € |
||
FRɑ |
Antibody-drug conjugate (ADC) |
Elahere® |
5 mg/mL |
– |
2 mg |
tba |
tba |
1.817,00 € |
||
CCR4 |
Monoclonal Antibody |
Poteligeo® |
4 mg/mL |
– |
0,5 mg |
-80 °C |
09/2023 |
312,30 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin